What is cd 20 and how does it impact how I should think about treatment for follicular lymphoma
According to the Leukemia & Lymphoma Society (LLS), CD20 is a protein found on the surface of most B-cell lymphomas, including follicular lymphoma. Think of it as a kind of "marker" or "flag" on lymphoma cells that helps your medical team identify and target these cancer cells.
The National Comprehensive Cancer Network (NCCN) Guidelines emphasize that CD20 is particularly important because it's the target for several effective treatments, particularly:
- Rituximab (Rituxan®)
- Obinutuzumab (Gazyva®)
- Other similar medications called "anti-CD20 antibodies"
According to ASCO (American Society of Clinical Oncology) Guidelines, testing for CD20 is a standard part of the initial lymphoma diagnosis process because:
- It helps confirm the specific type of lymphoma
- It helps determine if CD20-targeted therapies would be effective
- It influences treatment planning and options
Important considerations:
- Most follicular lymphomas are CD20-positive, which is generally favorable because it means these targeted treatments can be used
- Your doctor will test your lymphoma cells for CD20 as part of your initial diagnosis
- The presence of CD20 often influences which treatment combinations might work best for you
Always consult with your healthcare team about your specific CD20 status and how it impacts your individual treatment options. They can explain how your CD20 status specifically affects your treatment plan.
Would you like me to explain more about any specific CD20-targeted treatments or testing procedures?
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients (Lymphomas) — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 15, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients (Lymphomas) (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Lymphoma patients
Have your records handy? Add them to a private case for a deeper, personalized read →
Expert Webinars on Lymphoma
More questions about Lymphoma
- What is the financial impact of a Lymphoma diagnosis and how do I plan
- Been diagnosed with Classic B-Cell Follicular Lymphoma. On Friday I have my first treatment of Bendamustine and then...
- Follicular lymphoma: What innovations are available for liquid biopsy for FL
- Getting ready to start radiation for a knot on my head also going through chemo it's 15 minutes a day for 20 days...
- Hello! My diagnosis is classic follicular lymphoma high grade 3A. It was found through testing my tonsils after...
- Months post chemo ( follicular lymphoma) and life is back to almost normal. Several things that have shown up is...
- What should caregivers know about Lymphoma treatment
- What can I do if my insurance denies my lymphoma treatment